Raftar, a provider of radio frequency identification (RFID) and mobile application based logistics and distribution solutions for medical device manufacturers and distributors recently announced a "Risk-Free" way for qualified medical device companies to prove RFID will streamline sales and distribution operations for their business.
In the limited time offer, Raftar will deliver pilot participants a full bundle consisting of the Raftar Software Suite – its RFID-based warehouse and mobile, field service automation software – and will manage the entire 90-day pilot process from implementation and training through to successful completion. The RFID solution provided by Raftar will utilize Impinj's high performance Monza® tags and Speedway® readers. The "Risk-Free RFID" pilot will enable qualified companies to deploy an RFID-based case scheduling and inventory management and tracking solution that extends from a selected warehouse location to the point of consumption at the hospital in the field, with no up-front investment.
After the 90-day pilot, participating companies will have the option to discontinue the program with no obligation or deploy a fully functional production system, supported by a robust business case and real-world performance benchmarks.
"The driver here is to remove the uncertainty surrounding RFID in the medical devices industry," said Ismail Nalwala, Raftar's President and CEO. "Strong evidence exists globally that our technology can create dramatic operational efficiencies by slashing order processing times from 30 minutes to seconds and to help sales and customer service reps drive better service results for hospital and surgeons. The financial benefits continue through to inventory reduction and extend to better quality through order accuracy and item-level visibility. With the ‘Risk-Free RFID' Pilot program, Raftar hopes to remove the uncertainty and enable companies to get practical experience with our solution and RFID and formulate a go-forward strategy," says Nalwala.
"We are excited that Raftar is exposing more medical device companies to the benefits of the latest RFID technology. In 2010, we've seen a surge in the use of UHF RFID technology and rapid growth in the variety of RFID enabled devices," said Kerry Krause, vice president of marketing for Impinj. "Raftar's software solutions and medical device industry domain expertise combined with Impinj's hardware offerings, provide an optimal solution for accurate item-level counting of loaner kit items, including metal implants and instruments."
Companies interested in participating in the Risk-Free RFID pilot should visit Raftar's web site at http://www.raftarcorp.com/index.php/rfid-pilot for full program qualifications and registration details.
About Raftar Corp.
Raftar is a full service RFID solutions provider with extensive experience in the Health and Life Sciences industry developing turnkey solutions for leading Orthopedic Manufacturers and Pharmaceutical companies, consisting of equipment, software and implementation for the automation of sales and distribution tasks of high-value items. Raftar's software solutions automate business processes to help grow sales and improve operational performance through the use of automatic data capture technologies like RFID in the warehouse, mobile handheld applications for field service-based case scheduling and order tracking, and enterprise-wide item-level inventory tracking and visibility.
About Impinj, Inc.
Impinj, Inc. is the world's leading innovator in developing UHF Gen 2 RFID solutions for both item-level and supply-chain tagging. Impinj draws on its technical expertise and industry partnerships to deliver a wide range of products and solutions, comprising high-performance tag chips, readers, reader chips, software, antennas and systems integration. Impinj's products provide unprecedented performance, integration and cost effectiveness to a global customer base across numerous vertical markets with applications including inventory management, asset tracking, authentication and serialization. For more information, visit www.impinj.com.
SOURCE: Impinj, Inc.